EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic

Helen Huang, Keith S K Leung, Tulika Garg, Adele Mazzoleni, Goshen D Miteu, Farida Zakariya, Wireko A Awuah, Elaine T S Yin, Faaraea Haroon, Zarish Hussain, Narjiss Aji, Vikash Jaiswal iD und 1 weitere

Clinical Cardiology · 2023

DOI: 10.1002/clc.24059 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Cardiology, 2023. Verfasst von Helen Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Royal College of Surgeons in Ireland, Faculty of Medicine and Health Science, Dublin, Ireland. Hauptthemen laut MEDLINE: COVID-19, Hyperlipoproteinemia Type II, Atherosclerosis, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid pathway. The goal in managing FH is to reduce circulating low‐density lipoprotein cholesterol and, therefore, reduce the risk of developing atherosclerotic cardiovascular disease (ASCVD). Because FH patients were considered high risk groups due to an increased susceptible for contracting COVID‐19 infection, we hypothesized whether the effects of the pandemic hindered access to cardiovascular care. In this review, we conducted a literature search in databases Pubmed/Medline and ScienceDirect. We included a comprehensive analysis of findings from articles in English related and summarized the effects of the pandemic on cardiovascular care through direct and indirect effects. During the COVID‐19 pandemic, FH patients presented with worse outcomes and prognosis, especially those that have suffered from early ASCVD. This caused avoidance in seeking care due to fear of transmission. The pandemic severely impacted consultations with lipidologists and cardiologists, causing a decline in lipid profile evaluations. Low socioeconomic communities and ethnic minorities were hit the hardest with job displacements and lacked healthcare coverage respectively, leading to treatment nonadherence. Lock‐down restrictions promoted sedentary lifestyles and intake of fatty meals, but it is unclear whether these factors attenuated cardiovascular risk in FH. To prevent early atherogenesis in FH patients, universal screening programs, telemedicine, and lifestyle interventions are important recommendations that could improve outcomes in FH patients. However, the need to research in depth on the disproportionate impact within different subgroups should be the forefront of FH research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Hyperlipoproteinemia Type IIAtherosclerosisCardiovascular DiseasesHumansPandemicsCommunicable Disease ControlCholesterol, LDL

Stichwörter der Autor:innen

COVID-19atherosclerotic cardiovascular diseasecholesterolfamilial hypercholesterolemiageneticsmortality

Substanzen

Cholesterol, LDL

Autor:innen und Institutionen

  • Royal College of Surgeons in Ireland, Faculty of Medicine and Health Science, Dublin, Ireland.
  • Aston University Medical School, Faculty of Health & Life Sciences, Aston University, Birmingham, UK.
  • Epidemiology Research Unit, Cardiovascular Analytics Group, China-UK Collaboration, Hong Kong, China.
  • Government Medical College and Hospital Chandigarh, Chandigarh, India.
  • Barts and The London School of Medicine and Dentistry, London, UK.
  • School of Biosciences, Biotechnology, University of Nottingham, Nottingham, UK.

ORCID-Profile: Vikash Jaiswal, Gary Tse

Zitieren

APA

Huang, H., Leung, K. S. K., Garg, T., Mazzoleni, A., Miteu, G. D., Zakariya, F., Awuah, W. A., Yin, E. T. S., Haroon, F., Hussain, Z., Aji, N., Jaiswal, V., & Tse, G. (2023). Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic. Clinical Cardiology. https://doi.org/10.1002/clc.24059

Vancouver

Huang H, Leung KSK, Garg T, Mazzoleni A, Miteu GD, Zakariya F, et al. Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic. Clinical Cardiology. 2023. doi:10.1002/clc.24059

BibTeX
@article{Huang2023,
  author = {Huang, Helen and Leung, Keith S K and Garg, Tulika and Mazzoleni, Adele and Miteu, Goshen D and Zakariya, Farida and Awuah, Wireko A and Yin, Elaine T S and Haroon, Faaraea and Hussain, Zarish and Aji, Narjiss and Jaiswal, Vikash and Tse, Gary},
  title = {Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic},
  journal = {Clinical Cardiology},
  year = {2023},
  doi = {10.1002/clc.24059}
}
Kostenlos starten →